Multiple Sclerosis Room
In this room you can find updates and expert discussions about MS.
Regulatory Alerts, GP info: Neurological conditions, Specialist info: Neurology, Multiple Sclerosis Room
Ponesimod recommended for relapsing-remitting multiple sclerosis
Clinical trial evidence shows that people who have ponesimod have fewer relapses than people who have teriflunomide., according to NICE final draft guidance.
Regulatory Alerts, GP info: Neurological conditions, Specialist info: Neurology, Multiple Sclerosis Room
SMC accepts treatment for relapsing-remitting multiple sclerosis
Ofatumumab is accepted for restricted use within NHS Scotland.
Regulatory Alerts, GP info: Neurological conditions, Specialist info: Neurology, Multiple Sclerosis Room
Ozanimod not recommended for relapsing–remitting multiple sclerosis
Ozanimod's effect on the progression of disability is unclear and cost-effectiveness estimates are higher than what NICE normally considers an acceptable use of NHS resources, according to final guidance.
Regulatory Alerts, GP info: Neurological conditions, Specialist info: Neurology, Multiple Sclerosis Room
SMC accepts two neurology treatments
Medicines indicated in multiple sclerosis and CLN2 disease within NHS Scotland.
